Welcome to our dedicated page for 22Nd Century news (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22Nd Century stock.
News for 22nd Century Group, Inc. (Nasdaq: XXII) centers on its role in tobacco harm reduction, regulatory developments, capital structure actions and the commercialization of its VLN® reduced nicotine cigarette platform. Company announcements frequently highlight progress in expanding VLN® and partner VLN® distribution across additional U.S. states and retail chains, including launches with major convenience store operators and authorizations in a large majority of states.
Investors following XXII news will see updates on VLN® regulatory milestones, such as the original FDA Modified Risk Tobacco Product authorization, the filing of the VLN® MRTP renewal application, and the company’s public support for the FDA’s proposed Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products. Releases also discuss clinical research findings related to very low nicotine content cigarettes, including reductions in daily cigarette consumption and increased quit attempts among smokers using 95% reduced nicotine VLN® products.
Another recurring theme in 22nd Century’s news is financial and corporate developments. The company reports on balance sheet changes such as repayment and termination of senior secured debt, settlement of insurance claims related to prior facility incidents, and the use of non-dilutive cash proceeds as growth capital. News items also cover equity and preferred stock financings, at-the-market offering arrangements, and proposals for reverse stock splits and other shareholder approvals under Nasdaq Listing Rules.
In addition, XXII news includes corporate governance and investor relations events, such as participation in investor conferences, quarterly earnings webcasts, and shareholder letters reviewing strategic progress. For readers tracking the intersection of tobacco regulation, reduced nicotine technology and public company capital markets activity, the XXII news feed provides ongoing context on how 22nd Century is executing its harm reduction-focused strategy.
22nd Century Group (Nasdaq: XXII) announced that CEO Larry Firestone will present at the Emerging Growth Virtual Investor Conference on Wednesday, December 10, 2025 at 3:55 PM ET.
Investors can register to attend the live webcast and submit questions in advance; an archived webcast will be posted in the Events section of the company's investor relations website if attendees cannot join live.
Background: 22nd Century develops proprietary non‑GMO reduced‑nicotine tobacco (reported as 95% less nicotine vs traditional tobacco) and markets the FDA‑authorized VLN® combustible cigarette.
22nd Century Group (Nasdaq: XXII) announced receipt of $9.5 million in cash proceeds from a settlement with its insurer for business interruption related to the Grass Valley incident (November 2022).
Company leadership said the settlement strengthens the balance sheet and supports a shift from cleanup into a growth phase focused on expanding its core VLN® reduced-nicotine cigarette business. The release reiterates that VLN products contain 95% less nicotine and that the VLN cigarette is the only low-nicotine combustible cigarette authorized by the FDA in the United States.
22nd Century Group (NASDAQ: XXII) announced on Oct 23, 2025 that its VLN® reduced-nicotine cigarettes will begin sales at approximately 140 Circle K locations in Illinois. VLN® products are now authorized for sale in 45 states, with five states pending, and the company unveiled new marketing and consumer-education materials covering its VLN® combustible cigarette lineup.
The company highlights that its proprietary VLN® tobacco contains 95% less nicotine and that VLN® is the first and only combusted cigarette product authorized by the FDA under the agency's low-nicotine framework.
22nd Century Group (Nasdaq: XXII) will report third quarter 2025 results on November 4, 2025. The company will issue a press release at 6:00 AM ET and host a live webcast at 8:00 AM ET with CEO Larry Firestone and CFO Dan Otto reviewing financial results, recent progress, and 2025 plans.
The company highlights its VLN® combustible cigarette containing 95% less nicotine and notes VLN® is the only low‑nicotine combustible cigarette authorized by the FDA in the U.S. Investors can access the live and archived webcast via the company Events page at https://ir.xxiicentury.com/events.
22nd Century Group (Nasdaq: XXII) has submitted public comments supporting the FDA's proposed mandate to reduce nicotine content in cigarettes and certain combusted tobacco products. The company's submission highlights that their Very Low Nicotine Content (VLNC) technology could transform the industry within two years.
According to FDA's model, the proposed rule could prevent 48 million youth and young adults from starting smoking and avert 1.8 million tobacco-related deaths by 2060. The company's VLN® cigarettes, containing 95% less nicotine than traditional cigarettes, are currently the only FDA-authorized low nicotine combustible cigarettes in the U.S.
The initiative has received support from over 75 health care professional organizations, including the American Medical Association and American College of Cardiology, while facing opposition from major tobacco producers.
22nd Century Group (Nasdaq: XXII) has secured a $9.5 million cash settlement from insurers for business interruption claims related to the November 2022 Grass Valley incident. The settlement payment must be made within 45 days of the agreement's effective date.
The company, now debt-free, views this non-dilutive capital as crucial for growth rather than survival. CEO Larry Firestone emphasized that after addressing legacy issues over the past 22 months, the company is positioned to achieve profitability in 2026.
22nd Century Group specializes in tobacco harm reduction through its proprietary non-GMO reduced nicotine tobacco plants, which contain 95% less nicotine than traditional tobacco. Their flagship product, VLN® cigarette, is the only FDA-authorized low nicotine combustible cigarette in the United States.
22nd Century Group (Nasdaq: XXII) has announced a significant financial milestone by becoming debt-free after repaying its remaining $3.9 million senior secured debt following the completion of its Series A convertible preferred stock offering. The company has eliminated over $20 million in senior secured and subordinated debt under CEO Larry Firestone's leadership.
The financial restructuring has resulted in an approximate $9.1 million increase in adjusted pro forma net tangible book value ($1.05 per share). The company plans to utilize its capital to expand its very low nicotine tobacco leaf inventory in Q4 2025, with capacity to produce over 1 million cartons of VLN combustible products. The company's VLN® cigarettes, containing 95% less nicotine than traditional cigarettes, remain the only FDA-authorized low nicotine combustible cigarette in the United States.
22nd Century Group (Nasdaq: XXII), a tobacco products company focused on reducing smoking harms and nicotine addiction, has announced its participation in the upcoming HC Wainwright Conference. The company's leadership, including CEO Larry Firestone and CFO Dan Otto, will conduct investor meetings on September 9, 2025 at the Lotte New York Palace Hotel.
Interested investors can schedule meetings through their HC Wainwright representative or by contacting 22nd Century's Investor Relations directly.
22nd Century Group (Nasdaq: XXII) CEO Larry Firestone provided a comprehensive update on the company's VLN® reduced nicotine tobacco products and regulatory developments. The company announced two major partnerships with Smoker Friendly and Pinnacle for VLN® product distribution, with initial Pinnacle stocking orders shipped in August 2025.
The FDA's proposed Tobacco Product Standard for Nicotine Yield, expected by September 15, 2025, could mandate a 0.7mg/g maximum nicotine content. The company is expanding its VLN® product line to include 100mm cigarettes, international versions, and filtered cigars. Additionally, research is underway exploring potential links between their non-GMO low nicotine tobacco genetics and reduced levels of harmful TSNAs (Tobacco-Specific Nitrosamines).
22nd Century Group (Nasdaq: XXII), a tobacco products company focused on reducing smoking harms through nicotine addiction control, has announced its participation in the upcoming Emerging Growth Virtual Investor Conference.
CEO Larry Firestone and CFO Dan Otto will present on August 20, 2025 at 1:10 PM ET. Investors can register online to attend the virtual presentation and submit questions in advance. A replay will be available in the Events section of the company's IR website.